CompletedPhase 3NCT02308982

Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis

Studying Encephalitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Oxford
Principal Investigator
Andrew J Pollard, FRCPCH, PhD
University of Oxford
Intervention
Immunoglobulins, Intravenous (Privigen)(drug)
Enrollment
18 enrolled
Eligibility
16 years · All sexes
Timeline
2016 – 2022

Study locations (25)

Collaborators

National Institute for Health Research, United Kingdom · CSL Behring · University of Liverpool · University College London Hospitals · Guy's and St Thomas' NHS Foundation Trust · Liverpool University Hospitals NHS Foundation Trust · Great Ormond Street Hospital for Children NHS Foundation Trust

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02308982 on ClinicalTrials.gov

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Encephalitis →

← Back to all trials